Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Biochemical Pharmacology
|
April 6, 1993
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts
S M Blaney, J L Grem, F M Balis, et al.
Seminars in Oncology
|
April 1, 1992
Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations
J L Grem, E Chu, D Boarman, et al.
Archives of Internal Medicine
|
October 1, 1985
Massive skeletal muscle invasion by lymphoma
J L Grem, A J Neville, S C Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1988
Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases
J L Grem, D F Hoth, B Leyland-Jones, et al.
Oncology Reports
|
May 9, 1998
The utility of monitoring carcinoembyronic antigen during systemic therapy for advanced colorectal cancer
J L Grem, S M Steinberg, A P Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1995
The role of interferon-alpha as a modulator of fluorouracil and leucovorin
J L Grem, C J van Groeningen, A A Ismail, et al.
Oncology (Williston Park, N.Y.)
|
May 1, 1993
Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma
H R Alexander, J L Grem, H I Pass, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1993
Antimetabolites
E Chu, P G Johnston, C H Takimoto, et al.
Cancer
|
August 1, 1993
A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma
J L Grem, N McAtee, F Balis, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1994
Antimetabolites
E Chu, P G Johnston, J L Grem, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Biochemical Pharmacology
|
April 6, 1993
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts
S M Blaney, J L Grem, F M Balis, et al.
Seminars in Oncology
|
April 1, 1992
Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations
J L Grem, E Chu, D Boarman, et al.
Archives of Internal Medicine
|
October 1, 1985
Massive skeletal muscle invasion by lymphoma
J L Grem, A J Neville, S C Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1988
Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases
J L Grem, D F Hoth, B Leyland-Jones, et al.
Oncology Reports
|
May 9, 1998
The utility of monitoring carcinoembyronic antigen during systemic therapy for advanced colorectal cancer
J L Grem, S M Steinberg, A P Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1995
The role of interferon-alpha as a modulator of fluorouracil and leucovorin
J L Grem, C J van Groeningen, A A Ismail, et al.
Oncology (Williston Park, N.Y.)
|
May 1, 1993
Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma
H R Alexander, J L Grem, H I Pass, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1993
Antimetabolites
E Chu, P G Johnston, C H Takimoto, et al.
Cancer
|
August 1, 1993
A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma
J L Grem, N McAtee, F Balis, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1994
Antimetabolites
E Chu, P G Johnston, J L Grem, et al.
Page
of 12